First Human Trials Begin for AI-Designed Drug

June 27, 2023

(The Motley Fool via MSN) – Biotech firm Insilico Medicine said Monday that it entered an “AI-discovered-and-designed” drug into Phase 2 clinical trials involving human subjects, a first for the industry. The robots: they may not be so bad after all. (Read More)